▶ 調査レポート

呼吸器用薬の世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Respiratory Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。呼吸器用薬の世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Respiratory Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-13291資料のイメージです。• レポートコード:D005-13291
• 出版社/出版日:GlobalInfoResearch / 2020年5月
• レポート形態:英文、PDF、133ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥393,240 (USD3,480)▷ お問い合わせ
  Multi User¥589,860 (USD5,220)▷ お問い合わせ
  Corporate User¥786,480 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、呼吸器用薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。呼吸器用薬の種類別市場規模(アドベアー、シムビコートタービュヘイラー、スピリーバ、ゾレア、ベントリン、パルミコート、オルカンビ、レルベア / ブレオエリプタ、シングレア、エスブリエット)、用途別市場規模(病院、在宅医療)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):GSK、Air Liquide、Merck、Boehringer Ingelheim、Sunovion、AstraZeneca、Baxter、Omron、Novartis、Aradigm、Roche、Genentech、Beximco Pharmaceuticals、Hamilton Medical、Fisher & Paykel Healthcare、Draeger、Compumedics、Grifols、GE Healthcare、Pfizer
・地域別グローバル市場分析 2015年-2020年
・呼吸器用薬の北米市場(アメリカ、カナダ、メキシコ)
・呼吸器用薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・呼吸器用薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・呼吸器用薬の南米市場(ブラジル、アルゼンチン)
・呼吸器用薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:アドベアー、シムビコートタービュヘイラー、スピリーバ、ゾレア、ベントリン、パルミコート、オルカンビ、レルベア / ブレオエリプタ、シングレア、エスブリエット
・用途別分析:病院、在宅医療
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Respiratory Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Respiratory Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Respiratory Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Respiratory Drug market has been segmented into
Advair
Symbicort turbuhaler
Spiriva
Xolair
Ventolin
Pulmicort
Orkambi
Relvar/breo ellipta
Singulair
Esbriet

By Application, Respiratory Drug has been segmented into:
Hospitals
Home care

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Respiratory Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Respiratory Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Respiratory Drug market.

The report offers in-depth assessment of the growth and other aspects of the Respiratory Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Respiratory Drug Market Share Analysis
Respiratory Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Respiratory Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Respiratory Drug sales, revenue and market share for each player covered in this report.

The major players covered in Respiratory Drug are:
GSK
Air Liquide
Merck
Boehringer Ingelheim
Sunovion
AstraZeneca
Baxter
Omron
Novartis
Aradigm
Roche
Genentech
Beximco Pharmaceuticals
Hamilton Medical
Fisher & Paykel Healthcare
Draeger
Compumedics
Grifols
GE Healthcare
Pfizer

Among other players domestic and global, Respiratory Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Respiratory Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Respiratory Drug, with price, sales, revenue and global market share of Respiratory Drug in 2018 and 2019.
Chapter 3, the Respiratory Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Respiratory Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Respiratory Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Respiratory Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Respiratory Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Respiratory Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Advair
1.2.3 Symbicort turbuhaler
1.2.4 Spiriva
1.2.5 Xolair
1.2.6 Ventolin
1.2.7 Pulmicort
1.2.8 Orkambi
1.2.9 Relvar/breo ellipta
1.2.10 Singulair
1.2.11 Esbriet
1.3 Market Analysis by Application
1.3.1 Overview: Global Respiratory Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Home care
1.4 Overview of Global Respiratory Drug Market
1.4.1 Global Respiratory Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Air Liquide
2.2.1 Air Liquide Details
2.2.2 Air Liquide Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Air Liquide SWOT Analysis
2.2.4 Air Liquide Product and Services
2.2.5 Air Liquide Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boehringer Ingelheim SWOT Analysis
2.4.4 Boehringer Ingelheim Product and Services
2.4.5 Boehringer Ingelheim Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sunovion
2.5.1 Sunovion Details
2.5.2 Sunovion Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sunovion SWOT Analysis
2.5.4 Sunovion Product and Services
2.5.5 Sunovion Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AstraZeneca SWOT Analysis
2.6.4 AstraZeneca Product and Services
2.6.5 AstraZeneca Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Baxter
2.7.1 Baxter Details
2.7.2 Baxter Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Baxter SWOT Analysis
2.7.4 Baxter Product and Services
2.7.5 Baxter Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Omron
2.8.1 Omron Details
2.8.2 Omron Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Omron SWOT Analysis
2.8.4 Omron Product and Services
2.8.5 Omron Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novartis SWOT Analysis
2.9.4 Novartis Product and Services
2.9.5 Novartis Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Aradigm
2.10.1 Aradigm Details
2.10.2 Aradigm Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Aradigm SWOT Analysis
2.10.4 Aradigm Product and Services
2.10.5 Aradigm Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Roche
2.11.1 Roche Details
2.11.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Roche SWOT Analysis
2.11.4 Roche Product and Services
2.11.5 Roche Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Genentech
2.12.1 Genentech Details
2.12.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Genentech SWOT Analysis
2.12.4 Genentech Product and Services
2.12.5 Genentech Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Beximco Pharmaceuticals
2.13.1 Beximco Pharmaceuticals Details
2.13.2 Beximco Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Beximco Pharmaceuticals SWOT Analysis
2.13.4 Beximco Pharmaceuticals Product and Services
2.13.5 Beximco Pharmaceuticals Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Hamilton Medical
2.14.1 Hamilton Medical Details
2.14.2 Hamilton Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Hamilton Medical SWOT Analysis
2.14.4 Hamilton Medical Product and Services
2.14.5 Hamilton Medical Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Fisher & Paykel Healthcare
2.15.1 Fisher & Paykel Healthcare Details
2.15.2 Fisher & Paykel Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Fisher & Paykel Healthcare SWOT Analysis
2.15.4 Fisher & Paykel Healthcare Product and Services
2.15.5 Fisher & Paykel Healthcare Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Draeger
2.16.1 Draeger Details
2.16.2 Draeger Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Draeger SWOT Analysis
2.16.4 Draeger Product and Services
2.16.5 Draeger Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Compumedics
2.17.1 Compumedics Details
2.17.2 Compumedics Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Compumedics SWOT Analysis
2.17.4 Compumedics Product and Services
2.17.5 Compumedics Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Grifols
2.18.1 Grifols Details
2.18.2 Grifols Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Grifols SWOT Analysis
2.18.4 Grifols Product and Services
2.18.5 Grifols Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 GE Healthcare
2.19.1 GE Healthcare Details
2.19.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 GE Healthcare SWOT Analysis
2.19.4 GE Healthcare Product and Services
2.19.5 GE Healthcare Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Pfizer
2.20.1 Pfizer Details
2.20.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Pfizer SWOT Analysis
2.20.4 Pfizer Product and Services
2.20.5 Pfizer Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Respiratory Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Respiratory Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Respiratory Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Respiratory Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Respiratory Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Respiratory Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Respiratory Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Respiratory Drug Sales and Growth Rate (2015-2020)
4.3 Europe Respiratory Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Respiratory Drug Sales and Growth Rate (2015-2020)
4.5 South America Respiratory Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Respiratory Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Respiratory Drug Sales, Revenue and Market Share by Country
5.1.1 North America Respiratory Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Respiratory Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Respiratory Drug Sales and Growth Rate (2015-2020)
5.3 Canada Respiratory Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Respiratory Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Respiratory Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Respiratory Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Respiratory Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Respiratory Drug Sales and Growth Rate (2015-2020)
6.3 UK Respiratory Drug Sales and Growth Rate (2015-2020)
6.4 France Respiratory Drug Sales and Growth Rate (2015-2020)
6.5 Russia Respiratory Drug Sales and Growth Rate (2015-2020)
6.6 Italy Respiratory Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Respiratory Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Respiratory Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Respiratory Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Respiratory Drug Sales and Growth Rate (2015-2020)
7.3 Japan Respiratory Drug Sales and Growth Rate (2015-2020)
7.4 Korea Respiratory Drug Sales and Growth Rate (2015-2020)
7.5 India Respiratory Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Respiratory Drug Sales and Growth Rate (2015-2020)
7.7 Australia Respiratory Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Respiratory Drug Sales, Revenue and Market Share by Country
8.1.1 South America Respiratory Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Respiratory Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Respiratory Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Respiratory Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Respiratory Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Respiratory Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Respiratory Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Respiratory Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Respiratory Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Respiratory Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Respiratory Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Respiratory Drug Sales and Market Share by Type (2015-2020)
10.2 Global Respiratory Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Respiratory Drug Price by Type (2015-2020)
11 Global Respiratory Drug Market Segment by Application
11.1 Global Respiratory Drug Sales Market Share by Application (2015-2020)
11.2 Global Respiratory Drug Revenue Market Share by Application (2015-2020)
11.3 Global Respiratory Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Respiratory Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Respiratory Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Respiratory Drug Market Forecast (2021-2025)
12.2.2 Europe Respiratory Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Respiratory Drug Market Forecast (2021-2025)
12.2.4 South America Respiratory Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Respiratory Drug Market Forecast (2021-2025)
12.3 Respiratory Drug Market Forecast by Type (2021-2025)
12.3.1 Global Respiratory Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Respiratory Drug Market Share Forecast by Type (2021-2025)
12.4 Respiratory Drug Market Forecast by Application (2021-2025)
12.4.1 Global Respiratory Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Respiratory Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Respiratory Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Respiratory Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Respiratory Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Respiratory Drug Major Business
Table 9. GSK Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 10. GSK SWOT Analysis
Table 11. GSK Respiratory Drug Product and Services
Table 12. GSK Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Air Liquide Basic Information, Manufacturing Base and Competitors
Table 14. Air Liquide Respiratory Drug Major Business
Table 15. Air Liquide Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 16. Air Liquide SWOT Analysis
Table 17. Air Liquide Respiratory Drug Product and Services
Table 18. Air Liquide Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Respiratory Drug Major Business
Table 21. Merck Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 22. Merck SWOT Analysis
Table 23. Merck Respiratory Drug Product and Services
Table 24. Merck Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 26. Boehringer Ingelheim Respiratory Drug Major Business
Table 27. Boehringer Ingelheim Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 28. Boehringer Ingelheim SWOT Analysis
Table 29. Boehringer Ingelheim Respiratory Drug Product and Services
Table 30. Boehringer Ingelheim Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sunovion Basic Information, Manufacturing Base and Competitors
Table 32. Sunovion Respiratory Drug Major Business
Table 33. Sunovion Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 34. Sunovion SWOT Analysis
Table 35. Sunovion Respiratory Drug Product and Services
Table 36. Sunovion Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 38. AstraZeneca Respiratory Drug Major Business
Table 39. AstraZeneca Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 40. AstraZeneca SWOT Analysis
Table 41. AstraZeneca Respiratory Drug Product and Services
Table 42. AstraZeneca Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Baxter Basic Information, Manufacturing Base and Competitors
Table 44. Baxter Respiratory Drug Major Business
Table 45. Baxter Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 46. Baxter SWOT Analysis
Table 47. Baxter Respiratory Drug Product and Services
Table 48. Baxter Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Omron Basic Information, Manufacturing Base and Competitors
Table 50. Omron Respiratory Drug Major Business
Table 51. Omron Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 52. Omron SWOT Analysis
Table 53. Omron Respiratory Drug Product and Services
Table 54. Omron Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Novartis Basic Information, Manufacturing Base and Competitors
Table 56. Novartis Respiratory Drug Major Business
Table 57. Novartis Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 58. Novartis SWOT Analysis
Table 59. Novartis Respiratory Drug Product and Services
Table 60. Novartis Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Aradigm Basic Information, Manufacturing Base and Competitors
Table 62. Aradigm Respiratory Drug Major Business
Table 63. Aradigm Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 64. Aradigm SWOT Analysis
Table 65. Aradigm Respiratory Drug Product and Services
Table 66. Aradigm Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Roche Basic Information, Manufacturing Base and Competitors
Table 68. Roche Respiratory Drug Major Business
Table 69. Roche Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 70. Roche SWOT Analysis
Table 71. Roche Respiratory Drug Product and Services
Table 72. Roche Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Genentech Basic Information, Manufacturing Base and Competitors
Table 74. Genentech Respiratory Drug Major Business
Table 75. Genentech Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 76. Genentech SWOT Analysis
Table 77. Genentech Respiratory Drug Product and Services
Table 78. Genentech Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Beximco Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Beximco Pharmaceuticals Respiratory Drug Major Business
Table 81. Beximco Pharmaceuticals Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 82. Beximco Pharmaceuticals SWOT Analysis
Table 83. Beximco Pharmaceuticals Respiratory Drug Product and Services
Table 84. Beximco Pharmaceuticals Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Hamilton Medical Basic Information, Manufacturing Base and Competitors
Table 86. Hamilton Medical Respiratory Drug Major Business
Table 87. Hamilton Medical Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 88. Hamilton Medical SWOT Analysis
Table 89. Hamilton Medical Respiratory Drug Product and Services
Table 90. Hamilton Medical Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Fisher & Paykel Healthcare Basic Information, Manufacturing Base and Competitors
Table 92. Fisher & Paykel Healthcare Respiratory Drug Major Business
Table 93. Fisher & Paykel Healthcare Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 94. Fisher & Paykel Healthcare SWOT Analysis
Table 95. Fisher & Paykel Healthcare Respiratory Drug Product and Services
Table 96. Fisher & Paykel Healthcare Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Draeger Basic Information, Manufacturing Base and Competitors
Table 98. Draeger Respiratory Drug Major Business
Table 99. Draeger Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 100. Draeger SWOT Analysis
Table 101. Draeger Respiratory Drug Product and Services
Table 102. Draeger Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Compumedics Basic Information, Manufacturing Base and Competitors
Table 104. Compumedics Respiratory Drug Major Business
Table 105. Compumedics Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 106. Compumedics SWOT Analysis
Table 107. Compumedics Respiratory Drug Product and Services
Table 108. Compumedics Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Grifols Respiratory Drug Type and Application
Table 110. Grifols Respiratory Drug Major Business
Table 111. Grifols Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 112. Grifols SWOT Analysis
Table 113. Grifols Respiratory Drug Product and Services
Table 114. Grifols Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 116. GE Healthcare Respiratory Drug Major Business
Table 117. GE Healthcare Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 118. GE Healthcare SWOT Analysis
Table 119. GE Healthcare Respiratory Drug Product and Services
Table 120. GE Healthcare Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Pfizer Basic Information, Manufacturing Base and Competitors
Table 122. Pfizer Respiratory Drug Major Business
Table 123. Pfizer Respiratory Drug Total Revenue (USD Million) (2017-2018)
Table 124. Pfizer SWOT Analysis
Table 125. Pfizer Respiratory Drug Product and Services
Table 126. Pfizer Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. Global Respiratory Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 128. Global Respiratory Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 129. Global Respiratory Drug Sales by Regions (2015-2020) (K Pcs)
Table 130. Global Respiratory Drug Sales Market Share by Regions (2015-2020)
Table 131. Global Respiratory Drug Revenue by Regions (2015-2020) (USD Million)
Table 132. North America Respiratory Drug Sales by Countries (2015-2020) (K Pcs)
Table 133. North America Respiratory Drug Sales Market Share by Countries (2015-2020)
Table 134. North America Respiratory Drug Revenue by Countries (2015-2020) (USD Million)
Table 135. North America Respiratory Drug Revenue Market Share by Countries (2015-2020)
Table 136. Europe Respiratory Drug Sales by Countries (2015-2020) (K Pcs)
Table 137. Europe Respiratory Drug Sales Market Share by Countries (2015-2020)
Table 138. Europe Respiratory Drug Revenue by Countries (2015-2020) (USD Million)
Table 139. Asia-Pacific Respiratory Drug Sales by Regions (2015-2020) (K Pcs)
Table 140. Asia-Pacific Respiratory Drug Sales Market Share by Regions (2015-2020)
Table 141. Asia-Pacific Respiratory Drug Revenue by Regions (2015-2020) (USD Million)
Table 142. South America Respiratory Drug Sales by Countries (2015-2020) (K Pcs)
Table 143. South America Respiratory Drug Sales Market Share by Countries (2015-2020)
Table 144. South America Respiratory Drug Revenue by Countries (2015-2020) (USD Million)
Table 145. South America Respiratory Drug Revenue Market Share by Countries (2015-2020)
Table 146. Middle East & Africa Respiratory Drug Sales by Countries (2015-2020) (K Pcs)
Table 147. Middle East & Africa Respiratory Drug Sales Market Share by Countries (2015-2020)
Table 148. Middle East & Africa Respiratory Drug Revenue by Countries (2015-2020) (USD Million)
Table 149. Middle East & Africa Respiratory Drug Revenue Market Share by Countries (2015-2020)
Table 150. Global Respiratory Drug Sales by Type (2015-2020) (K Pcs)
Table 151. Global Respiratory Drug Sales Share by Type (2015-2020)
Table 152. Global Respiratory Drug Revenue by Type (2015-2020) (USD Million)
Table 153. Global Respiratory Drug Revenue Share by Type (2015-2020)
Table 154. Global Respiratory Drug Sales by Application (2015-2020) (K Pcs)
Table 155. Global Respiratory Drug Sales Share by Application (2015-2020)
Table 156. Global Respiratory Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 157. Global Respiratory Drug Market Share Forecast by Regions (2021-2025)
Table 158. Global Respiratory Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 159. Global Respiratory Drug Market Share Forecast by Type (2021-2025)
Table 160. Global Respiratory Drug Sales Forecast by Application (2021-2025)
Table 161. Global Respiratory Drug Market Share Forecast by Application (2021-2025)
Table 162. Direct Channel Pros & Cons
Table 163. Indirect Channel Pros & Cons
Table 164. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Respiratory Drug Picture
Figure 2. Global Sales Market Share of Respiratory Drug by Type in 2019
Figure 3. Advair Picture
Figure 4. Symbicort turbuhaler Picture
Figure 5. Spiriva Picture
Figure 6. Xolair Picture
Figure 7. Ventolin Picture
Figure 8. Pulmicort Picture
Figure 9. Orkambi Picture
Figure 10. Relvar/breo ellipta Picture
Figure 11. Singulair Picture
Figure 12. Esbriet Picture
Figure 13. Respiratory Drug Sales Market Share by Application in 2018
Figure 14. Hospitals Picture
Figure 15. Home care Picture
Figure 16. Global Respiratory Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 17. United States Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Canada Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Mexico Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Germany Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. France Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. UK Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Russia Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Italy Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. China Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Japan Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Korea Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. India Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Southeast Asia Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Australia Respiratory Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 31. Brazil Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Egypt Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Saudi Arabia Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 34. South Africa Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Turkey Respiratory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Global Respiratory Drug Sales Market Share by Manufacturer in 2019
Figure 37. Global Respiratory Drug Revenue Market Share by Manufacturer in 2019
Figure 38. Top 3 Respiratory Drug Manufacturer (Revenue) Market Share in 2019
Figure 39. Top 6 Respiratory Drug Manufacturer (Revenue) Market Share in 2019
Figure 40. Key Manufacturer Market Share Trend
Figure 41. Global Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 42. Global Respiratory Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. Global Respiratory Drug Revenue Market Share by Regions (2015-2020)
Figure 44. Global Respiratory Drug Revenue Market Share by Regions in 2018
Figure 45. North America Respiratory Drug Sales and Growth Rate (2015-2020)
Figure 46. Europe Respiratory Drug Sales and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Respiratory Drug Sales and Growth Rate (2015-2020)
Figure 48. South America Respiratory Drug Sales and Growth Rate (2015-2020)
Figure 49. Middle East & Africa Respiratory Drug Sales and Growth Rate (2015-2020)
Figure 50. North America Respiratory Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. North America Respiratory Drug Sales Market Share by Countries (2015-2020)
Figure 52. North America Respiratory Drug Sales Market Share by Countries in 2018
Figure 53. North America Respiratory Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 54. North America Respiratory Drug Revenue Market Share by Countries in 2018
Figure 55. United States Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Canada Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Mexico Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Europe Respiratory Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Europe Respiratory Drug Revenue Market Share by Countries (2015-2020)
Figure 60. Europe Respiratory Drug Revenue Market Share by Countries in 2019
Figure 61. Germany Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. UK Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. France Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Russia Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Italy Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Asia-Pacific Respiratory Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. Asia-Pacific Respiratory Drug Sales Market Share by Regions 2019
Figure 68. Asia-Pacific Respiratory Drug Revenue Market Share by Regions 2019
Figure 69. China Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Korea Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. India Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Southeast Asia Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. South America Respiratory Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. South America Respiratory Drug Sales Market Share by Countries in 2019
Figure 76. South America Respiratory Drug Revenue Market Share by Countries in 2019
Figure 77. Brazil Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Argentina Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Middle East and Africa Respiratory Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 80. Middle East and Africa Respiratory Drug Sales Market Share by Countries in 2019
Figure 81. Middle East and Africa Respiratory Drug Revenue Market Share by Countries (2015-2020)
Figure 82. Middle East and Africa Respiratory Drug Revenue Market Share by Countries in 2019
Figure 83. Saudi Arabia Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Egypt Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Turkey Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 86. South Africa Respiratory Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 87. Global Respiratory Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 88. Global Respiratory Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 89. North America Sales Respiratory Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. Europe Sales Respiratory Drug Market Forecast (2021-2025) (K Pcs)
Figure 91. Asia-Pacific Sales Respiratory Drug Market Forecast (2021-2025) (K Pcs)
Figure 92. South America Sales Respiratory Drug Market Forecast (2021-2025) (K Pcs)
Figure 93. Middle East & Africa Sales Respiratory Drug Market Forecast (2021-2025) (K Pcs)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel